scroll down

The online pharmaceutical market is booming, and strengthening big data supervision is key to preventing risks

2021-07-02

The COVID-19 pandemic has altered public medication purchasing and healthcare-seeking habits, driving rapid growth in the pharmaceutical e-commerce sector. Effective regulation and risk prevention will be key priorities moving forward. Recently, Li Danrong, Deputy Director of the Data Center at the Southern Institute of Pharmaceutical Economics, National Medical Products Administration, stated at the Jiangsu First Medical Device Informatization Development Summit and Jiangsu Medical Device Big Data Center Unveiling Ceremony that in 2020, online sales of pharmaceuticals reached 159.3 billion yuan, an increase of 59.1 billion yuan year-on-year, representing a 59% increase. The absolute value of online growth was more than three times that of offline sales.

Biomedical industry is entering a period of opportunity, with financial innovation helping enterprises seize the commanding heights of competition

2021-07-01

On June 29, SDAX Capital announced the launch of a US$400 million dedicated China healthcare fund ("SDAX Capital China Healthcare Fund V"). This fund will continue SDAX Capital's investment logic in China's healthcare sector, further deploying investments across the entire industry value chain, focusing on key disease areas, and establishing a comprehensive Chinese healthcare ecosystem. The fund will focus on early investment opportunities in China's healthcare industry, covering four sub-sectors: new drug development, medical devices and diagnostics, healthcare services, and medical IT/digital healthcare.
< 1...515253...81 >